RecruitingPhase 2NCT05535166

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Studying Medulloblastoma

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: St. Jude Children's Research Hospital
Principal Investigator: Giles W. Robinson, MD
St. Jude Children's Research Hospital
Intervention: Surgical resection(procedure)
Enrollment: 130 enrolled
Eligibility: All sexes
Timeline: 2022 – 2035

Study locations (10)

Lucille Packard Children's Hospital Stanford, Palo Alto, California, United States
Orlando Health Arnold Palmer Hospital for Children, Orlando, Florida, United States
St. Joseph's Children's Hospital, Tampa, Florida, United States
C.S. MOTT Children's Hospital, University of Michigan, Ann Arbor, Michigan, United States
Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota, United States
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center, Dallas, Texas, United States
Cook Children's Medical Center, Fort Worth, Texas, United States
Texas Children's Hospital, Houston, Texas, United States
Primary Children's Hospital, Salt Lake City, Utah, United States

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05535166 on ClinicalTrials.gov

Other trials for Medulloblastoma

Additional recruiting or active studies for the same condition.

See all trials for Medulloblastoma →

← Back to all trials